Electronic Prescribing: Becoming Mainstream PracticeJune 2008Page 3
Table of Contents
Foreword ...............................................................................................................2
Executive Summary ...............................................................................................5
Team and Process................................................................................................10SECTION I: INTRODUCTION TO ELECTRONIC PRESCRIBING ..............................12
Definition of Electronic Prescribing .................................................................. 12
Electronic Prescribing Statem ent of Principles ................................................. 15
Why Electronic Prescribing I s I m portant ......................................................... 16
High Volume and Growing Complexity of Prescriptions 16
Reducing Medication Errors 16
Reducing the Burden of Callbacks and Rework 17
Improving Medication Adherence 18
Cost Savings 19
Stakeholders in Electronic Prescribing and the Value They Derive................... 20
Current State of Adoption ................................................................................ 23
Physician Adoption 23
E-Prescription Volume 24
Pharmacy Adoption 25
Technology Vendor Readiness 25
E-Prescribing Growth by State 26
PBM/Payer Connectivity 28
Current Landscape in Public Policy .................................................................. 30
Congress 30
The Administration 31 The States 33
Challenges of E-Prescribing ............................................................................. 35
Costs of E-Prescribing ...................................................................................... 37
SECTION II. The Prescribing Process ..................................................................38
Signing On ....................................................................................................... 39
I dentifying the Patient ..................................................................................... 39
Selecting the Drug, Entering Param eters, Signing ........................................... 40
Leave a Comment